Gwenn Hansen - Net Worth and Insider Trading
Gwenn Hansen Net Worth
The estimated net worth of Gwenn Hansen is at least $1 Million dollars as of 2024-11-29. Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc and owns about 50,670 shares of Nurix Therapeutics Inc (NRIX) stock worth over $1 Million. Details can be seen in Gwenn Hansen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gwenn Hansen has not made any transactions after 2024-10-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gwenn Hansen
Gwenn Hansen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gwenn Hansen owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .
Click here to see the complete history of Gwenn Hansen’s form 4 insider trades.
Insider Ownership Summary of Gwenn Hansen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NRIX | Nurix Therapeutics Inc | 2024-10-30 | Chief Scientific Officer |
Gwenn Hansen Latest Holdings Summary
Gwenn Hansen currently owns a total of 1 stock. Gwenn Hansen owns 50,670 shares of Nurix Therapeutics Inc (NRIX) as of October 30, 2024, with a value of $1 Million.
Latest Holdings of Gwenn Hansen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NRIX | Nurix Therapeutics Inc | 2024-10-30 | 50,670 | 21.23 | 1,075,724 |
Holding Weightings of Gwenn Hansen
Gwenn Hansen Form 4 Trading Tracker
According to the SEC Form 4 filings, Gwenn Hansen has made a total of 22 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 3,437 shares on October 30, 2024, which brought Gwenn Hansen around $83,554.
Insider Trading History of Gwenn Hansen
- 1
Gwenn Hansen Trading Performance
Gwenn Hansen Ownership Network
Gwenn Hansen Owned Company Details
What does Nurix Therapeutics Inc do?
Who are the key executives at Nurix Therapeutics Inc?
Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and EVP and COO Stefani Wolff .
Nurix Therapeutics Inc (NRIX) Insider Trades Summary
Over the past 18 months, Gwenn Hansen made 6 insider transaction in Nurix Therapeutics Inc (NRIX) with a net sale of 14,703. Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van ,
In summary, during the past 3 months, insiders sold 40,683 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 40,683 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.
Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nurix Therapeutics Inc Insider Transactions
Gwenn Hansen Mailing Address
Above is the net worth, insider trading, and ownership report for Gwenn Hansen. You might contact Gwenn Hansen via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.